InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-24 · accession 0001649094-24-000021 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-25 2024-06-24 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $75.64 -15.0K 478.9K -3% -$1.13M
D 2024-06-25 2024-06-24 PCVX PICKERING GRANT CEO, Dir M - OptEx $2.03 +15.0K 493.9K +3% +$30.4K
D 2024-06-25 2024-06-24 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 +15.0K 197.3K +8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-24 S D 10,341 $75.39 483,547 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $74.735 to $75.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-06-24 M A 15,000 $2.03 493,888 D — —
3 Common Common Stock 2024-06-24 S D 4,471 $76.17 479,076 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $75.74 to $76.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2024-06-24 S D 188 $76.80 478,888 D — — (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $76.74 to $76.81. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (right to buy) 2024-06-24 M A 15,000 $0.00 197,327 D $2.03 · — to 2028-07-23 15,000 Common Stock (F7) Stock Option is fully vested and exercisable.